Navigation Links
ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year
Date:3/20/2013

JACKSONVILLE, Fla., March 20, 2013 /PRNewswire-iReach/ --  ENCO Pharmaceutical Development's Jacksonville, FL Facility Completes Successful FDA Audit

ENCO Pharmaceutical Development, Inc. (EPDI) is pleased to announce the completion of a successful FDA inspection of its Jacksonville FL facility.  The audit was a directed Pre-approval Inspection (PAI). 

The audit occurred between March 7th and 8th, 2013.  Upon the completion of the inspection, the investigator reported no findings and no Form 483 was issued.

"As a company we understand the value of maintaining a high level of compliance," said Mark Inman , Ph.D., VP and Director of Quality Assurance.  "Not only do we want to ensure adherence to the existing regulatory requirements, EPDI also remains connected to the various regulatory bodies we work with to keep the company at the forefront of changes in the regulatory industry."

This audit marks the second consecutive month that an EPDI facility has been audited by the FDA.  In February, auditors inspected EPDI's Cary, NC facility.  "Between the two audits, our company has experienced nearly 5 days of intensive inspection by the FDA with no 483's or observations to report," Mark Inman continued. 

The audit covered thorough reviews of general systems such as training, equipment calibration/qualification, SOP's, protocols and methods and involved a variety of technical areas including analytical development and release testing.

ENCO Pharmaceutical Development Inc. provides a broad spectrum of pharmaceutical development and analytical services from its facilities in Jacksonville, FL and Cary, NC.  The company works with a variety of organi
'/>"/>

SOURCE ENCO Pharmaceutical Development, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... and MOUNTAIN VIEW, Calif. , ... BSX ) announces that it has signed ... venture-backed medical device company that develops, manufactures and ... guided transluminal drainage of targeted areas within the ... this week. The Xlumena portfolio ...
(Date:4/1/2015)... April 1, 2015  The first national study ... supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ... of children with ADHD were receiving behavioral therapy ... Control and Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity ... published today in The Journal of Pediatrics ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... YORK, Dec. 29, 2010 Reportlinker.com announces that a ... Regenerative Medicine Markets ... way of treating injured and diseased human tissue by ... As such, astounding new advancements in the ability to ...
... 2010 Reportlinker.com announces that a new market ... 2010-2015 In-depth Research Report on China ... Report SummaryBased on the ... General Administration of Custom, Ministry of Commerce , ...
Cached Medicine Technology:Reportlinker Adds Regenerative Medicine Markets 2Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2
(Date:4/1/2015)... 2015 (PRWEB) April 01, 2015 The Path ... most extreme jungle adventure you could ever embark upon. Trips ... days. Endorsed by the Philippine Department of Tourism, these trips ... the rainforest, but very few people have ever been in ... Officer. , Armed with nothing more than a backpack full ...
(Date:4/1/2015)... Taking an important step forward in the ... Commission for Nursing Education Accreditation (NLN CNEA) , the ... CNEA Board of Commissioners. Working with executive director Judith ... will provide leadership and direction to accreditation services and ... nursing programs that seek accreditation from the CNEA. , ...
(Date:4/1/2015)... IL, Bethesda, MD, Alexandria, VA (PRWEB) April 01, ... Clinical Pathology (ASCP), the College of American Pathologists ... the American Society of Clinical Oncology (ASCO) today ... on the use of molecular marker testing for ... evidence-based guideline will help establish standard molecular marker ...
(Date:4/1/2015)... April 01, 2015 Dr Roz Kamani, ... she is now offering her patients an opportunity to ... can participate in “Beauty Days”, which is an exclusive ... Roz Kamani’s Kitsilano Skin Care Clinic. It is attended ... patients about the latest products and services that are ...
(Date:4/1/2015)... April 01, 2015 Tempaper has joined ... new virtual giving campaign that will raise critical funds ... fighting muscle disease across the United States. , Throughout ... through Tempaperdesigns.com will automatically receive free domestic ... strength and urgently needed progress to children and adults ...
Breaking Medicine News(10 mins):Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3
... In what they are calling a new direction ... scientists have made an important finding about what happens ... and related dementias. The results are published in the ... Stuart Feinstein, professor of Molecular, Cellular and ...
... American Headache Society (AHS) science meeting here this weekend say ... the most promise for winning the battle against the disease. ... 40 % say an increase in public funds is more ... more than early intervention in a migraine attack (28%), migraine ...
... -- A new study suggests that the brain,s left and ... study, one of the few that have explored how the ... that "differences in left and right brain function influence the ... is looking on a page, but only when these words ...
... A natural nutritional supplement, marketed for the last decade as ... quality of life for female cancer survivors, according to researchers ... will be presented today at the 2011 American Society of ... quality of life issues for female cancer survivors, Kathryn M. ...
... available in German . Fat-rich food ... signalling pathways, through which the neurotransmitters in the brain ... Max Planck Institute for Neurological Research and the Cluster ... (CECAD) at the University of Cologne have clarified an ...
... by the Harvard School of Public Health and The Boston ... reform legislation enacted in 2006, 21% oppose it while 6% ... about the law. The percentage of residents supporting the law ... law varied by party affiliation, with 77% of Democrats, 60% ...
Cached Medicine News:Health News:UCSB scientists discover new direction in Alzheimer's research 2Health News:UCSB scientists discover new direction in Alzheimer's research 3Health News:Reading Arabic or English May Tax Brain Differently 2Health News:Supplement found to improve quality of life for female cancer survivors 2Health News:Supplement found to improve quality of life for female cancer survivors 3Health News:Insulin action in the brain can lead to obesity 2Health News:Insulin action in the brain can lead to obesity 3Health News:Support for Massachusetts landmark health reform law rises in 2011 2Health News:Support for Massachusetts landmark health reform law rises in 2011 3
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
... EX accelerators are true ... Varian multileaf collimation and ... which enable you to ... computer-driven IMRT treatments, as ...
The Clinac 2100 C/D family of accelerators are reliable, easy-to-use, flexible and cost-effective systems....
Based on the clinically proven ACS MULTI-LINK Stent, ULTRA is a coronary stent system specifically designed for use in larger vessels. This innovative system utilizes a unique stent pattern to give y...
Medicine Products: